Nation | by Maureen Ongala
Forty Kenyans will participate in the Kenya Medical Research Institute (KEMRI) Covid-19 vaccine trials which will start in a few weeks.
KEMRI Director-General Prof Kombe Yeri said the institution is still acquiring requisite ethical and regulatory approvals before it begins the trials on ChAdOx1 nCoV-19 vaccine.
“We were conducting several preparations ahead of the trials. First, it was important for us to get all valid licences from relevant authorities…
